🇯🇵 Paxlovid (Copackaged) in Japan

PMDA authorised Paxlovid (Copackaged) on 10 February 2022

Marketing authorisation

PMDA — authorised 10 February 2022

  • Marketing authorisation holder: PFIZER JAPAN INC
  • Status: approved

Paxlovid (Copackaged) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Japan

Frequently asked questions

Is Paxlovid (Copackaged) approved in Japan?

Yes. PMDA authorised it on 10 February 2022.

Who is the marketing authorisation holder for Paxlovid (Copackaged) in Japan?

PFIZER JAPAN INC holds the Japanese marketing authorisation.